Gadoteridol vs Nivolumab

## Gadoteridol vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Gadoteridol** and **Nivolumab**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Gadoteridol — N/A; Nivolumab — 27 days.

## Chemical Properties

**Type**: Gadoteridol — Small molecule; Nivolumab — Antibody.